¸ßÁéÃô¶ÈÍÃάÉúËØD£¨VD£©elisaÊÔ¼ÁºÐ

ÐͺÅ:

¸ßÎȶ¨ÐÔÍÿ¹ÈËÐļ¡¼¡¸Æµ°°×¿¹Ì壨Anti-cTn Ab£©elisaÊÔ¼ÁºÐ

ÐͺÅ:

Íÿ¹È˼¡ºìµ°°×¿¹Ì壨anti-HMP Ab£©elisaÊÔ¼ÁºÐ

ÐͺÅ:

ÍÃϸ°û¼äÕ³¸½·Ö×Ó1£¨ICAM-1£©elisaÊÔ¼ÁºÐ

ÐͺÅ:

¸ßÁéÃô¶ÈÍÃϸ¾úÖ¬µ°°×£¨BLP£©elisaÊÔ¼ÁºÐ

ÐͺÅ:

¸ßÎȶ¨ÐÔÍÃÏËÁ¬µ°°×£¨FN£©elisaÊÔ¼ÁºÐ

ÐͺÅ:

ÍÃÏËÈÜø£¨plasmin£©elisaÊÔ¼ÁºÐ

ÐͺÅ:

¸ßÁéÃô¶ÈÍÃÏËÈÜøԭ¼¤»îÎïÒÖÖÆÒò×Ó1£¨PAI-1£©elisaÊÔ¼ÁºÐ

ÐͺÅ:

¸ßÎȶ¨ÐÔÍÃÏËάµ°°×Ô­£¨Fbg£©elisaÊÔ¼ÁºÐ

ÐͺÅ:

ÍÃõ£»ù¸¨Ã¸A;µ¨¹Ì´¼õ£»ùתÒÆø£¨ACAT£©elisaÊÔ¼ÁºÐ

ÐͺÅ:

¸ßÁéÃô¶ÈÍÃÐļ¡¼¡¸Æµ°°×¢ñ£¨cTn-¢ñ£©elisaÊÔ¼ÁºÐ

ÐͺÅ:

¸ßÎȶ¨ÐÔÍÃÐÄÄÆËØ£¨ANP£©elisaÊÔ¼ÁºÐ

ÐͺÅ:

ÍÃѪ¹Ü½ôÕÅËØ1-7£¨ANG 1-7£©elisaÊÔ¼ÁºÐ

ÐͺÅ:

¸ßÁéÃô¶ÈÍÃѪ¹Ü½ôÕÅËØ??£¨Ang ??£©elisaÊÔ¼ÁºÐ

ÐͺÅ:

¸ßÎȶ¨ÐÔÍÃѪ¹Ü½ôÕÅËØת»¯Ã¸£¨ACE£©elisaÊÔ¼ÁºÐ

ÐͺÅ:

ÍÃѪ¹ÜÄÚƤÉú³¤Òò×ÓÊÜÌå1£¨VEGFR-1£©elisaÊÔ¼ÁºÐ

ÐͺÅ:

¸ßÁéÃô¶ÈÍÃѪ¹ÜÄÚƤϸ°ûÉú³¤Òò×Ó£¨VEGF£©elisaÊÔ¼ÁºÐ

ÐͺÅ:

¸ßÎȶ¨ÐÔÍÃѪ¹ÜÄÚƤϸ°ûÕ³¸½·Ö×Ó1£¨VCAM-1;CD£©elisaÊÔ¼ÁºÐ

ÐͺÅ:

ÍÃѪ¹ÜÐÔѪÓѲ¡Òò×Ó£¨vWF£©elisaÊÔ¼ÁºÐ

ÐͺÅ:

¸ßÁéÃô¶ÈÍÃѪºìËØÑõºÏø1£¨HO-1£©elisaÊÔ¼ÁºÐ

ÐͺÅ: